Related Experiment Video
Updated: Aug 12, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Mycobacterium tuberculosis in lung transplant recipients
R A Miller1, L A Lanza, J N Kline
1Department of Medicine, Veterans Affairs Administration Medical Center, Iowa City, Iowa, USA.
Diagnosing and treating Mycobacterium tuberculosis is challenging in transplant recipients due to immunosuppression, increasing risks of primary infection and reactivation. This review covers tuberculosis in lung transplant patients.
Area of Science:
- Immunology
- Infectious Diseases
- Transplantation Medicine
Background:
- Immunosuppressive therapy in transplant recipients significantly increases susceptibility to infections.
- Transplant recipients face risks of primary tuberculosis infection and reactivation of latent disease.
- Tuberculosis diagnosis is complicated in lung transplant recipients by concurrent pulmonary issues.
Observation:
- A case report details a patient who succumbed to disseminated Mycobacterium tuberculosis 12 weeks post-lung transplantation.
- The patient's death highlights the severe risks associated with tuberculosis in this vulnerable population.
Findings:
- Lung transplant recipients are at a higher risk for both primary and reactivated tuberculosis.
- Pulmonary tuberculosis diagnosis is particularly challenging in the post-lung transplant setting.
- Disseminated tuberculosis can be a fatal complication in lung transplant recipients.
Implications:
- Early diagnosis and vigilant management of tuberculosis are critical in lung transplant recipients.
- Understanding the unique challenges of tuberculosis in transplant patients is essential for improving outcomes.
- Further research into preventative strategies and diagnostic tools for tuberculosis in immunosuppressed individuals is warranted.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
06:15Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis